Terms: = Head and neck cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
1889 results:
1. LymphoDose: a lymphocyte dose estimation framework-application to brain radiotherapy.
de Kermenguy F; Benzazon N; Maury P; Vauclin R; M'hamdi M; Cifliku V; Limkin E; Diallo I; Morel D; Milewski C; Clémenson C; Mondini M; Deutsch E; Robert C
Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38593817
[No Abstract] [Full Text] [Related]
2. Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells.
Salama M; Ali A; Ibrahim FAR; Elabd S
Med Oncol; 2024 Apr; 41(5):105. PubMed ID: 38573558
[TBL] [Abstract] [Full Text] [Related]
3. Biodosimetric analysis of head and neck cancer patients undergoing radiotherapy by dicentric chromosome aberration assay.
Agarwal N; Rathi AK; Kapoor S; Singh K; Arora S; Jindal A; Prabhat K; Kaushik H
J Cancer Res Ther; 2024 Jan; 20(1):321-326. PubMed ID: 38554341
[TBL] [Abstract] [Full Text] [Related]
4.
Cytryn SL; Pandit-Taskar N; Lumish MA; Maron SB; Gu P; Ku GY; Chou JF; Capanu M; Antoine A; Loegel D; Feder L; Philemond S; Lyashchenko SK; Lewis JS; Paroder V; Srivastava A; Tang LH; Schoder H; Janjigian YY
J Nucl Med; 2024 May; 65(5):722-727. PubMed ID: 38514081
[TBL] [Abstract] [Full Text] [Related]
5. Advances in testing for human papillomavirus -mediated head and neck cancer.
Mehanna H; Alemany L; von Buchwald C
Curr Opin Oncol; 2024 May; 36(3):143-146. PubMed ID: 38506408
[TBL] [Abstract] [Full Text] [Related]
6. Functional Laryngectomy and Quality of Life in Survivors of head and neck cancer With Intractable Aspiration.
Evangelista L; Nativ-Zeltzer N; Bewley A; Birkeland AC; Abouyared M; Kuhn M; Cates DJ; Farwell DG; Belafsky P
JAMA Otolaryngol Head Neck Surg; 2024 Apr; 150(4):335-341. PubMed ID: 38451502
[TBL] [Abstract] [Full Text] [Related]
7. FD-Net: Feature Distillation Network for Oral Squamous Cell Carcinoma Lymph Node Segmentation in Hyperspectral Imagery.
Zhang X; Li Q; Li W; Guo Y; Zhang J; Guo C; Chang K; Lovell NH
IEEE J Biomed Health Inform; 2024 Mar; 28(3):1552-1563. PubMed ID: 38446656
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of the outcome of 12 cases of facial nerve tumors].
Shao Z; Zhou M; Yang J; Wang K
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Mar; 38(3):225-229. PubMed ID: 38433692
[No Abstract] [Full Text] [Related]
9. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Guigay J; Ortholan C; Vansteene D; Cupissol D; Even C; Kaminsky MC; Sire C; Blot E; Debourdeau P; Bozec L; Saada-Bouzid E; Fayette J; Dalloz P; Pointreau Y; Caer HL; Falandry C; Digue L; Braccini A; Lopez S; Guillet P; Michel C; Cheurfa N; Schwob D; Bourhis J; Mertens C; Aupérin A;
Lancet Healthy Longev; 2024 Mar; 5(3):e182-e193. PubMed ID: 38432247
[TBL] [Abstract] [Full Text] [Related]
10. Adenoid cystic carcinoma of the parotid and submandibular glands in children and young adults: A population-based study.
Phillips AL; Li C; Liang J; Sheyn A; Rastatter JC; Chelius DC; Orbach D; Richard C
Pediatr Blood Cancer; 2024 May; 71(5):e30928. PubMed ID: 38418934
[TBL] [Abstract] [Full Text] [Related]
11. Revisiting Feeding Tube Utilization in Oropharynx cancer: 6-Year Prospective Registry Analysis.
Anderson BJ; Moreno AC; Qing Y; Lee JJ; Johnson FM; Lango MN; Barbon CEA; Tripuraneni L; Sahli A; Piper V; Gross N; Fuller CD; Lai SY; Myers JN; Hutcheson KA
Otolaryngol Head Neck Surg; 2024 May; 170(5):1319-1330. PubMed ID: 38353360
[TBL] [Abstract] [Full Text] [Related]
12. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Besse B; Pons-Tostivint E; Park K; Hartl S; Forde PM; Hochmair MJ; Awad MM; Thomas M; Goss G; Wheatley-Price P; Shepherd FA; Florescu M; Cheema P; Chu QSC; Kim SW; Morgensztern D; Johnson ML; Cousin S; Kim DW; Moskovitz MT; Vicente D; Aronson B; Hobson R; Ambrose HJ; Khosla S; Reddy A; Russell DL; Keddar MR; Conway JP; Barrett JC; Dean E; Kumar R; Dressman M; Jewsbury PJ; Iyer S; Barry ST; Cosaert J; Heymach JV
Nat Med; 2024 Mar; 30(3):716-729. PubMed ID: 38351187
[TBL] [Abstract] [Full Text] [Related]
13. Oral health related quality of life in head and neck cancer survivors within the first year following treatment: a cross-sectional study in Karachi, Pakistan.
Qamar S; Rozi S; Sawani S; Awan MS; Akhtar S; Siddiqui MI; Abbas SA; Taimoor S; Raza Khan F
Sci Rep; 2024 Jan; 14(1):2560. PubMed ID: 38297035
[TBL] [Abstract] [Full Text] [Related]
14. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
15. Evolution of radiation-induced temporal lobe injury after intensity-modulated radiation therapy in nasopharyngeal carcinoma: a large cohort retrospective study.
Hou J; He Y; Li H; Ai Z; Lu Q; Zeng B; Xie C; Yu X
Radiat Oncol; 2024 Jan; 19(1):9. PubMed ID: 38243277
[TBL] [Abstract] [Full Text] [Related]
16. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PandA trial.
Verschoor YL; van de Haar J; van den Berg JG; van Sandick JW; Kodach LL; van Dieren JM; Balduzzi S; Grootscholten C; IJsselsteijn ME; Veenhof AAFA; Hartemink KJ; Vollebergh MA; Jurdi A; Sharma S; Spickard E; Owers EC; Bartels-Rutten A; den Hartog P; de Miranda NFCC; van Leerdam ME; Haanen JBAG; Schumacher TN; Voest EE; Chalabi M
Nat Med; 2024 Feb; 30(2):519-530. PubMed ID: 38191613
[TBL] [Abstract] [Full Text] [Related]
17. Role of tumor budding and fibrotic cancer stroma in head and neck squamous cell carcinoma.
Mitha M; Aden D; Zaheer S; Alvi Y; Chintamani
Pathol Res Pract; 2024 Jan; 253():155052. PubMed ID: 38176309
[TBL] [Abstract] [Full Text] [Related]
18. Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer.
Cho BC; Chiu CH; Massarelli E; Buchschacher GL; Goto K; Overbeck TR; Loong HHF; Chee CE; Garrido P; Dong X; Fan Y; Lu S; Schwemmers S; Bordogna W; Zeuner H; Osborne S; John T
Lung Cancer; 2024 Feb; 188():107442. PubMed ID: 38171156
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic Performance of [
Ventura D; Dittmann M; Büther F; Schäfers M; Rahbar K; Hescheler D; Claesener M; Schindler P; Riemann B; Seifert R; Roll W
J Nucl Med; 2024 Feb; 65(2):192-198. PubMed ID: 38164565
[TBL] [Abstract] [Full Text] [Related]
20. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
[Next]
